SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-002384
Filing Date
2023-02-09
Accepted
2023-02-09 16:48:04
Documents
16
Period of Report
2023-02-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-20230208.htm   iXBRL 8-K 100429
2 EX-1.1 life-ex1_1.htm EX-1.1 404219
3 EX-5.1 life-ex5_1.htm EX-5.1 28226
4 GRAPHIC img106332022_0.jpg GRAPHIC 29364
5 GRAPHIC img106332022_1.jpg GRAPHIC 29364
  Complete submission text file 0000950170-23-002384.txt   806005

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20230208_lab.xml EX-101.LAB 13352
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20230208.xsd EX-101.SCH 2470
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20230208_pre.xml EX-101.PRE 10992
10 EXTRACTED XBRL INSTANCE DOCUMENT life-20230208_htm.xml XML 4708
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 23606980
SIC: 2836 Biological Products, (No Diagnostic Substances)